| Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging SOS Osman, E Russell, RB King, K Crowther, S Jain, C McGrath, ... Radiation Oncology 14, 1-13, 2019 | 22 | 2019 |
| Prostate cancer treated with brachytherapy; an exploratory study of dose-dependent biomarkers and quality of life SOS Osman, S Horn, D Brady, SJ McMahon, ABM Yoosuf, D Mitchell, ... Radiation Oncology 12, 1-12, 2017 | 7 | 2017 |
| TRUFU: therapeutic radiographer undertaking follow up for prostate cancer patients SM Hetherington, T Gilleece, P Shepherd, K Crowther, J O'Sullivan, ... Radiography 24 (4), 298-303, 2018 | 6 | 2018 |
| A pilot study of patient reported outcomes evaluating treatment related symptoms and quality of life for men receiving high dose rate brachytherapy combined with hypo … K Crowther, A Cole, P Shiels, S Jain, P Shepherd, D Mitchell Technical Innovations & Patient Support in Radiation Oncology 9, 18-25, 2019 | 3 | 2019 |
| Coincidental splenic irradiation and risk of functional hyposplenism in oesophageal cancer treatment R Ellis, AJ Cole, J O’Hare, G Whitten, K Crowther, C Harrison Journal of Medical Imaging and Radiation Oncology 65 (7), 925-930, 2021 | 2 | 2021 |
| Evaluation of patient experience and satisfaction during gastrointestinal radiotherapy treatment K Crowther Education Today 32, 779-781, 2020 | 1 | 2020 |
| Therapeutic radiographer prescribing practices in the United Kingdom: Questionnaire survey K Crowther, N Carey, S McFadden, K Stenner, C Hughes Radiography 30 (3), 964-970, 2024 | | 2024 |
| Palliative haemostatic radiotherapy in gastro-oesophageal cancer-a single centre experience K Crowther, J O’Hare, C Harrison Radiotherapy and Oncology 152, S1073-S1073, 2020 | | 2020 |
| Utilization of PROMs in hypo-fractionated radiotherapy for localized prostate cancer K Crowther, A Cole, P Shiels, S Jain, P Shepherd, D Mitchell All Ireland radiation Therapy Study Day, 2019 | | 2019 |
| A pilot study: Utilization of PROMs in hypo-fractionated radiotherapy for localized prostate cancer. K Crowther, A Cole, P Shiels, S Jain, P Shepherd, D Mitchell ESTRO 38, 2019 | | 2019 |
| EP-2207 PROMs: Transperineal insertion of prostate markers–results from a prospective clinical trial A O'Neill, K Crowther, D Mitchell, S Jain, A Hounsell, J O'Sullivan Radiotherapy and Oncology 133, S1216-S1217, 2019 | | 2019 |
| OC-0098 Gated vs coached DIBH treatment in left sided breast cancer radiotherapy: a single centre study K Crowther, S Osman, S O'Hare, S Gray, D Holland, H Vennard, G Hanna Radiotherapy and Oncology 133, S50-S51, 2019 | | 2019 |
| EP-2385: Initial experience of ExacTrac X-Ray imaging for prostate patients with implanted fiducial markers K Crowther, A O'Neill, C Agnew, D McKay, J Smith, A McCrum, P Shiels, ... Radiotherapy and Oncology 127, S1248, 2018 | | 2018 |
| PV-0365: CASPIR Trial: Calculi as an alternative to fiducial markers for IGRT in localised prostate cancer A O'Neill, R King, K Crowther, S Osman, S Jain, AR Hounsell, ... Radiotherapy and Oncology 127, S186, 2018 | | 2018 |
| EP-2397: Therapeutic Radiographer follow up for prostate cancer patients S Hetherington, K Crowther, S Jain, D Mitchell, J O'Sullivan, L Shum, ... Radiotherapy and Oncology 127, S1255, 2018 | | 2018 |
| A research interventional clinic within the NHS to enable participation in prostate clinical trials K Crowther, A O’Neill, D Mitchell, G Totten, S Murray, J McCarthy, ... 36th European SocieTy for Radiotherapy & Oncology (ESTRO) Annual Meeting, 2017 | | 2017 |
| PO-0970: Prostate brachytherapy; DNA damage biomarker (gH2AX) induction rate correlates with late toxicity S Osman, S Horn, D Brady, SJ McMahon, ABM Yoosuf, D Mitchell, ... Radiotherapy and Oncology 123, S535-S536, 2017 | | 2017 |
| An audit evaluating the frequency of patient re-preparation after CBCT analysis in prostate IMRT K Crowther Radiotherapy and Oncology 123, S1008-S1008, 2017 | | 2017 |
